The treatment of small cell lung cancer (SCLC) is a challenge for all specialists involved. New treatments have been added to the therapeutic armamentarium in recent months, but efforts must continue to improve both survival and quality of life. Advances in surgery and radiotherapy have resulted in prolonged survival times and fewer complications, while more careful patient selection has led to increased staging accuracy. Developments in the field of systemic therapy have resulted in changes to clinical guidelines and the management of patients with advanced disease, mainly with the introduction of immunotherapy. In this article, we describe recent improvements in the management of patients with SCLC, review current treatments, and discuss future lines of research.
Keywords: Atezolizumab; Durvalumab; Immunotherapy; Prophylactic cranial irradiation; Small cell lung cancer; Stereotactic body radiotherapy; Whole-brain radiotherapy.
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.